• Achieve Life Sciences (ACHV) was identified as one of the top gaining US stocks, rising around 8% in a single trading session.
• Aktis Oncology (AKTS) was identified as one of the top gaining US stocks, rising around 9% in a single trading session.
• Alamar Biosciences (ALMR) was identified as one of the top gaining US stocks, rising around 13% in a single trading session.
• Alpha Tau Medical (DRTS) was identified as one of the top gaining US stocks, rising around 11% in a single trading session.
• Apollomics (APLM) was identified as one of the top gaining US stocks, rising around 7% in a single trading session.
• Ascendis Pharma (ASND) was identified as one of the top gaining US stocks, rising around 10% in a single trading session.
• AbCellera (ABCL) was identified as one of the top gaining US stocks, rising about 10% in a single trading session.
The EMA's Committee for Medicinal Products for Human Use issued a positive re-examination opinion recommending EU approval of Daybue (trofinetide) for neurobehavioral symptoms of Rett syndrome in patients aged five and older — positioning it to become the first pharmacological therapy approved for this …
ProQR Therapeutics priced a registered direct offering of common shares at $1.81 per share targeting $50 million in gross proceeds, with Eli Lilly and Company committing $9.2 million via a concurrent private placement to preserve its pro rata ownership stake in the company.
Shuttle Pharmaceutical Holdings' recently acquired subsidiary United Dogecoin is evaluating proprietary data center and behind-the-meter power assets in Idaho and Alberta while electrifying initial ElphaPex miners, positioning the company to shift from basic Dogecoin mining toward owned digital infrastructure with potential artificial intelligence hosting …